Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews

BACKGROUND: Aliskiren is a newly developed drug. Its role in lowering BP has been recognized. However, the role of aliskiren in treating heart and renal diseases are still controversial. OBJECTIVE: To evaluate the existing evidence about clinical efficacy, safety and tolerability of aliskiren monoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qiyuan, Shen, Jiantong, Lu, Jingya, Jiang, Qi, Wang, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164287/
https://www.ncbi.nlm.nih.gov/pubmed/32303191
http://dx.doi.org/10.1186/s12872-020-01442-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164287/
https://www.ncbi.nlm.nih.gov/pubmed/32303191
http://dx.doi.org/10.1186/s12872-020-01442-z

Ejemplares similares